GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chong Kun Dang Pharmaceutical Corp (XKRX:185750) » Definitions » 5-Year Yield-on-Cost %

Chong Kun Dang Pharmaceutical (XKRX:185750) 5-Year Yield-on-Cost % : 1.69 (As of May. 18, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Chong Kun Dang Pharmaceutical 5-Year Yield-on-Cost %?

Chong Kun Dang Pharmaceutical's yield on cost for the quarter that ended in Dec. 2023 was 1.69.


The historical rank and industry rank for Chong Kun Dang Pharmaceutical's 5-Year Yield-on-Cost % or its related term are showing as below:

XKRX:185750' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.55   Med: 1.36   Max: 2.31
Current: 1.69


During the past 11 years, Chong Kun Dang Pharmaceutical's highest Yield on Cost was 2.31. The lowest was 0.55. And the median was 1.36.


XKRX:185750's 5-Year Yield-on-Cost % is ranked worse than
58.88% of 501 companies
in the Drug Manufacturers industry
Industry Median: 2.09 vs XKRX:185750: 1.69

Competitive Comparison of Chong Kun Dang Pharmaceutical's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Chong Kun Dang Pharmaceutical's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chong Kun Dang Pharmaceutical's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chong Kun Dang Pharmaceutical's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Chong Kun Dang Pharmaceutical's 5-Year Yield-on-Cost % falls into.



Chong Kun Dang Pharmaceutical 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Chong Kun Dang Pharmaceutical is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Chong Kun Dang Pharmaceutical  (XKRX:185750) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Chong Kun Dang Pharmaceutical 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Chong Kun Dang Pharmaceutical's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Chong Kun Dang Pharmaceutical (XKRX:185750) Business Description

Traded in Other Exchanges
N/A
Address
368 Chungjungro-3Ga, Seodaemun-gu, Seoul, KOR, 120-756
Chong Kun Dang Pharmaceutical Corp. is a manufacturer of antibiotics. The company manufactures and distributes over 130 ethical, OTC pharmaceuticals and pharmaceutical active ingredients, primarily focusing on the application of its advanced technologies in fermentation and organic synthesis. The product range includes Rifampicin (antituberculosis), DMCT (raw material for Minocycline), Cephalosporins, 7-ACA and other intermediates of Cephalosporins, Cyclosporin A (immunosuppressant) and Lovastatin (antihyperlipidaemic agent).

Chong Kun Dang Pharmaceutical (XKRX:185750) Headlines

No Headlines